Clin Endosc.  2023 Mar;56(2):183-184. 10.5946/ce.2023.037.

Endoscopic ultrasound-guided tissue acquisition for personalized treatment in pancreatic adenocarcinoma

• Woo SM

• KMID: 2540734
• DOI: http://doi.org/10.5946/ce.2023.037

Reference

1. Hyeon DY, Nam D, Han Y, et al. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes. Nat Cancer. 2023; 4:290–307.

2. O'Kane GM, Lowery MA. Moving the needle on precision medicine in pancreatic cancer. J Clin Oncol. 2022; 40:2693–2705.

3. Chung MJ, Park SW, Kim SH. Clinical and technical guideline for endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumor: Korean Society of Gastrointestinal Endoscopy (KSGE). Clin Endosc. 2021; 54:161–181.

4. Kandel P, Nassar A, Gomez V, et al. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial. Endoscopy. 2021; 53:376–382.

5. Park JK, Lee JH, Noh DH, et al. Factors of endoscopic ultrasound-guided tissue acquisition for successful next-generation sequencing in pancreatic ductal adenocarcinoma. Gut Liver. 2020; 14:387–394.

6. Okuno N, Hara K, Mizuno N, et al. Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of pancreatic cancer. Clin Endosc. 2023; 56:221–228.

7. Roy-Chowdhuri S, Goswami RS, Chen H, et al. Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol. 2015; 123:659–668.